Ziprasidone

Imran Qureshi, PharmD, BCPP

INDICATIONS

INDICATIONS

INDICATIONS

FDA

FDA

FDA

  • Schizophrenia
  • Mixed or manic episodes in bipolar I disorder as monotherapy
  • Maintenance treatment of bipolar I disorder as an adjunct to lithium or valproate
  • Acute treatment of agitation in adults with schizophrenia (IM)

NON-FDA APPROVED USES

NON-FDA APPROVED USES

NON-FDA APPROVED USES

  • Management of delirium
  • Adjunct to antidepressants in treating major depressive disorder

There's more to see -- the rest of this topic is available only to subscribers.

© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.